Results 131 to 140 of about 31,333 (185)

Clinicopathological Features of Methotrexate-associated Lymphoproliferative Disorders in the Gastrointestinal Tract. [PDF]

Intern Med
Edagawa T, Iwagami H, Akamatsu T, Nakano S, Wakita M, Konishi T, Nakatani Y, Uenoyama Y, Yamashita Y.   +8 more
europepmc   +1 more source

Epstein-Barr virus-related lymphoproliferative disorders of the skin. [PDF]

Dermatol Reports
Ferrara G, Gualandi A.
europepmc   +1 more source

Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: Diagnostic overlaps and defining features. [PDF]

Hum Pathol
Volaric AK, Fedoriw Y.
europepmc   +1 more source

The Post-transplant Lymphoproliferative Disorders-Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) Study Methods and Protocol. [PDF]

Transplant Direct
Dharnidharka VR, Wylie KM, Wylie TN, Ruzinova MB, Goss CW, Storch GA, Mehta-Shah N, Byers D, Walther L, Jaza L, Gu H, Agarwal M, Green M, Moore E, Swerdlow SH, Silveira F, Marks LJ, Gratzinger D, Bagg A, Law SC, Gandhi M.   +20 more
europepmc   +1 more source

Isolated Muscular NK/T Cell Lymphoma: A Rare Presentation of Post-Transplant Lymphoproliferative Disorders. [PDF]

Indian J Nucl Med
Srivastava S, Jilhare P, Nazar AH, Ora M, Gambhir S.   +4 more
europepmc   +1 more source

Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders. [PDF]

J Clin Immunol
Palacios-Ortega M, Guerra-Galán T, Jiménez-Huete A, García-Aznar JM, Pérez-Guzmán M, Mansilla-Ruiz MD, Mendiola ÁV, López CP, Hornero EM, Rodriguez AP, Cortijo AP, Polo Zarzuela M, Morales MM, Mandly EA, Cárdenas MC, Carrero A, García CJ, Bolaños E, Íñigo B, Medina F, de la Fuente E, Ochoa-Grullón J, García-Solís B, García-Carmona Y, Fernández-Arquero M, Benavente-Cuesta C, de Diego RP, Rider N, Sánchez-Ramón S.   +28 more
europepmc   +1 more source

Institutional Experience of Lymphoproliferative Disorders with Initial Diagnosis Made via Fine Needle Aspiration at Otolaryngology Clinic. [PDF]

Acta Med Acad
Hrizat AS, Gong J, Gargano SM.
europepmc   +1 more source

Retrospective Evaluation of Clinical and Follow-Up Outcomes in Primary Cutaneous CD30⁺ Lymphoproliferative Disorders [PDF]

Turk J Haematol
Şanlı H, Aydemir AT, Kalay Yıldızhan İ, Heper A, Kuzu I, Kırmızı A, Botsalı A, Akay BN.   +7 more
europepmc   +1 more source

Molecular significance of circRNAs in malignant lymphoproliferative disorders: pathogenesis and novel biomarkers or therapeutic targets. [PDF]

Am J Cancer Res
Long BY, Wang Y, Hao SH, Shi G.
europepmc   +1 more source